Trial intelligence / Profile preview

Hemodynamics in primary and secondary hypertension

2006-002065-39Phase 4Completed

Sponsor
Ilkka Pörsti Research Group
Start
May 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of nitroglycerin and salbutamol in essential hypertension and Secondary hypertension, sponsored by Ilkka Pörsti Research Group. Started May 2006; status: completed.

02

Drugs

nitroglycerinsalbutamol
03

Conditions

essential hypertensionSecondary hypertension

Beyond the preview

Go deeper on 2006-002065-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002065-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call